BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23356330)

  • 1. Fovea and foveation in Parkinson's disease.
    Bodis-Wollner I; Glazman S; Yerram S
    Behav Neurosci; 2013 Apr; 127(2):139-50. PubMed ID: 23356330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foveal vision is impaired in Parkinson's disease.
    Bodis-Wollner I
    Parkinsonism Relat Disord; 2013 Jan; 19(1):1-14. PubMed ID: 22998939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Line bisection in Parkinson's disease: investigation of contributions of visual field, retinal vision, and scanning patterns to visuospatial function.
    Laudate TM; Neargarder S; Cronin-Golomb A
    Behav Neurosci; 2013 Apr; 127(2):151-63. PubMed ID: 23356329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific impairment of visual spatial covert attention mechanisms in Parkinson's disease.
    Sampaio J; Bobrowicz-Campos E; André R; Almeida I; Faria P; Januário C; Freire A; Castelo-Branco M
    Neuropsychologia; 2011 Jan; 49(1):34-42. PubMed ID: 21075128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography in Parkinson's disease: is the retina a biomarker?
    Lee JY; Ahn J; Kim TW; Jeon BS
    J Parkinsons Dis; 2014; 4(2):197-204. PubMed ID: 24518436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
    Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
    Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visuo-cognitive dysfunctions in Parkinson's disease.
    Antal A; Bandini F; Kéri S; Bodis-Wollner I
    Clin Neurosci; 1998; 5(2):147-52. PubMed ID: 10785841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?
    van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J
    Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Visuoperceptual processing in Parkinson's disease: from the retina to the frontal cortex].
    Ruiz-Sánchez de León JM; Fernández-Guinea S
    Rev Neurol; 2005 May 1-15; 40(9):557-62. PubMed ID: 15898018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy in Parkinson Disease.
    Bodis-Wollner I
    J Neural Transm (Vienna); 2009 Nov; 116(11):1493-501. PubMed ID: 19730784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attentional and perceptual impairments in Parkinson's disease with visual hallucinations.
    Koerts J; Borg MA; Meppelink AM; Leenders KL; van Beilen M; van Laar T
    Parkinsonism Relat Disord; 2010 May; 16(4):270-4. PubMed ID: 20153970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficits in saccadic eye-movement control in Parkinson's disease.
    Chan F; Armstrong IT; Pari G; Riopelle RJ; Munoz DP
    Neuropsychologia; 2005; 43(5):784-96. PubMed ID: 15721191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson's disease.
    Pinkhardt EH; Ding Y; Slotnick S; Kassubek J; Ludolph AC; Glazman S; Selesnick I; Bodis-Wollner I
    J Neural Transm (Vienna); 2020 Sep; 127(9):1275-1283. PubMed ID: 32676747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response times for visually guided saccades in persons with Parkinson's disease: a meta-analytic review.
    Chambers JM; Prescott TJ
    Neuropsychologia; 2010 Mar; 48(4):887-99. PubMed ID: 19913042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating visual misperceptions in Parkinson's disease: a novel behavioral paradigm.
    Shine JM; Halliday GH; Carlos M; Naismith SL; Lewis SJ
    Mov Disord; 2012 Apr; 27(4):500-5. PubMed ID: 22488861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal psychophysical visual perception in Parkinson's disease patients.
    Crevits L
    Acta Neurol Belg; 2003 Jun; 103(2):83-7. PubMed ID: 12892001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention and visual dysfunction in Parkinson's disease.
    Botha H; Carr J
    Parkinsonism Relat Disord; 2012 Jul; 18(6):742-7. PubMed ID: 22503538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
    Bertrand JA; Bedetti C; Postuma RB; Monchi O; Génier Marchand D; Jubault T; Gagnon JF
    Mov Disord; 2012 Dec; 27(14):1781-8. PubMed ID: 23147270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oculo-Visual Dysfunction in Parkinson's Disease.
    Armstrong RA
    J Parkinsons Dis; 2015; 5(4):715-26. PubMed ID: 26599301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the basal ganglia in the control of automatic visuospatial attention.
    Fielding J; Georgiou-Karistianis N; White O
    J Int Neuropsychol Soc; 2006 Sep; 12(5):657-67. PubMed ID: 16961947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.